Related Experiment Video
Updated: Jan 16, 2026
Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models
Published on: June 20, 2025
Identification of structural predictors of lung function improvement in adults with cystic fibrosis treated with
Guillaume Chassagnon1, Rafael Marini2, Valentin Ong2
1Department of Radiology, Hôpital Cochin, AP-HP.Centre, Université Paris Cité, Paris 75014, France; Unité HeKA, Université Paris Cité, Inria, INSERM, Paris 75015, France; Université Paris Cité, Paris 75006, France.
Purpose:
The purpose of this study was to evaluate the relationship between structural abnormalities on CT and lung function prior to and after initiation of elexacaftor-tezacaftor-ivacaftor (ETI) in adults with cystic fibrosis (CF) using a deep learning model.
Materials And Methods:
A deep learning quantification model was developed using 100 chest computed tomography (CT) examinations of patients with CF and 150 chest CT examinations of patients with various other bronchial diseases to quantify seven types of abnormalities. This model was then applied to an independent dataset of CT examinations of 218 adults with CF who were treated with ETI. The relationship between structural abnormalities and percent predicted forced expiratory volume in one second (ppFEV1) was examined using general linear regression models.
Results:
The deep learning model performed as well as radiologists for the quantification of the seven types of abnormalities. Chest CT examinations obtained before to and one year after the initiation of ETI were analyzed. The independent structural predictors of ppFEV1 prior to ETI were bronchial wall thickening (P = 0.011), mucus plugging (P < 0.001), consolidation/atelectasis (P < 0.001), and mosaic perfusion (P < 0.001). An increase in ppFEV1 after initiation of ETI independently correlated with a decrease in bronchial wall thicknening (-49 %; P = 0.004), mucus plugging (-92 %; P < 0.001), centrilobular nodules (-78 %; P = 0.009) and mosaic perfusion (-14 %; P < 0.001). Younger age (P < 0.001), greater mucus plugging extent (P = 0.016), and centrilobular nodules (P < 0.001) prior to ETI initiation were independent predictors of ppFEV1 improvement.
Conclusion:
A deep learning model can quantify CT lung abnormalities in adults with CF. Lung function impairment in adults with CF is associated with muco-inflammatory lesions on CT, which are largely reversible with ETI, and with mosaic perfusion, which appear less reversible and is presumably related to irreversible damage. Predictors of lung function improvement are a younger age and a greater extent of muco-inflammatory lesions obstructing the airways.
More Related Videos
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
10:44Three-Dimensional Phase Resolved Functional Lung Magnetic Resonance Imaging
Published on: June 21, 2024
Related Concept Videos
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:25Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
01:24Cystic Fibrosis: Management
Sinus disease and chronic...
01:23Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
01:22Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:47Lung Capacity